… drugs and late-stage pipeline drugs, advancements in treatment … slowly worsening kidney failure, heart … motivates drug developers to allocate … drugs. In-Market Drugs Drug Overview Mechanism of Action Regulatory Status Clinical Trial Results Drug …

… trial evaluated patients who were refractory to or had relapsed following treatment … These data supported the FDA’s July 2024 … transplant, transplant types included kidney (28.6%), heart ( … of which were treatment related. Most treatment-emergent serious …

… a human heart and a kidney developed from human stem cells in … fundamental questions in developmental biology. BioWorld Science Conferences Drug design, drug delivery and …

… develop its candidates, including completing the phase 1b trial.  … Lead kidney disease drug: Filspari Recent news: FDA accepted … medications: Thiola for the treatment of cystinuria, a rare inherited kidney … The market for kidney disease drugs is set for …

… From Two Trials For Hypertension Drug Candidate “The Explore-CKD trial is the … fourth trial showing clinically meaningful effects of lorundrostat for the treatment of … surrogate of kidney protection…Along with the successful pivotal trials, Launch-HTN …

… . The sections were developed with 3,3’- … drug interactions.Modern pharmacological research has shown that all the above-mentioned drugs … blinded, controlled trial. J Tradit Chin Med. 2020;40( … bone pain medications in the treatment of rheumatic diseases …

… and large-scale clinical trials because of its complex, … surrogate indicators, to guide pharmacological therapy in CKD patients, … and treatment of insulin resistance in patients with chronic kidney disease … to hotspots review. Front Med. 2024;11:1472413. doi …

The European Commission (EC) has granted marketing authorisation for Averoa’s oral therapy Xoanacyl for chronic kidney disease (CKD), a condition characterised by the progressive loss of kidney function. This decision follows the European Medicines Agency’ …

… was the demonstration that pharmacological inhibition or genetic … trials. The molecular definition of ferroptosis in kidney … this work galvanizes the development of novel biomarkers reflecting … effective treatments. As the global burden of chronic kidney …

… gel is in Phase II trials to treat venous leg … Aurase Wound Gel in the treatment of calciphylaxis ulcers, but … also affect people with normal kidney function. AWG presents a … fast track designation will enable drug development and accelerate the review …